News

Archer-Daniels-Midland: We Are Again Right On Target, Slowdown Is Part Of Normalization

4 Mins read

Investment Thesis

Review

We initially covered Archer-Daniel-Midland at $89.41 in February this year with a “Sell” rating, and it subsequently realized an 18% decline to $72.62 by June. At that point, we changed our rating to “Hold”, expecting the price movement

Read the full article here

Related posts
News

NOV: Strategic Hold Amid Transition Toward 2026 Cycle Convergence (NYSE:NOV)

1 Mins read
This article was written by Follow A trader, researcher, and analyst possessing experience spanning years in the domains of US stocks, transnational…
News

Franklin Mutual Beacon Fund Q3 2025 Commentary (undefined:BEGRX)

1 Mins read
Franklin Resources, Inc. [NYSE:BEN] is a global investment management organization with subsidiaries operating as Franklin Templeton and serving clients in over 150…
News

Novo Nordisk's Stock Is Not Cheap [Downgrade] (NYSE:NVO)

1 Mins read
This article was written by Follow I am a highly experienced Chief Financial Officer (CFO) with a strong background in the oilfield…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *